Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders

Mass spectrometry based protein biomarkers and drug target discovery and clinical diagnosis in Age-Related progressing neurodegenerative diseases

(2022) Ishita Agrawal et al.   DRUG METABOLISM REVIEWS

Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease

(2021) Ondrej Libiger et al.   Alzheimers & Dementia

14-3-3 Proteins: Novel Pharmacological Targets in Neurodegenerative Diseases

(2021) F. Sanders Pair et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB

(2021) Stefanie Lerche et al.   MOVEMENT DISORDERS

Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis

(2021) Jessica Root et al.   NEUROBIOLOGY OF DISEASE

Pathways to Parkinson’s disease: a spotlight on 14-3-3 proteins

(2021) E. Giusto et al.   npj Parkinsons Disease

A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study

(2021) Sofia Bergström et al.   Molecular Neurodegeneration

Deficient neurotransmitter systems and synaptic function in frontotemporal lobar degeneration—Insights into disease mechanisms and current therapeutic approaches

(2021) Nadine Huber et al.   MOLECULAR PSYCHIATRY

PEBP1/RKIP behavior: a mirror of actin-membrane organization

(2020) Françoise Schoentgen et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Targeted Mass Spectrometry Suggests Beta-Synuclein as Synaptic Blood Marker in Alzheimer’s Disease

(2020) Patrick Oeckl et al.   JOURNAL OF PROTEOME RESEARCH

The MUC6/AP2A2 Locus and Its Relevance to Alzheimer’s Disease: A Review

(2020) Peter T Nelson et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Cerebrospinal fluid neuronal pentraxin receptor as a biomarker of long-term progression of Alzheimer's disease: a 24-month follow-up study

(2020) Bryant Lim et al.   NEUROBIOLOGY OF AGING

Genetics of synucleins in neurodegenerative diseases

(2020) José Brás et al.   ACTA NEUROPATHOLOGICA

Phosphorylated tau interactome in the human Alzheimer’s disease brain

(2020) Eleanor Drummond et al.   BRAIN

Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics

(2020) Betty M Tijms et al.   BRAIN

Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer’s disease

(2020) Steffen Halbgebauer et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF

(2020) Walter A. Boiten et al.   Cells

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease

(2019) Simon Sjödin et al.   Alzheimers Research & Therapy

Rab GTPases: Switching to Human Diseases

(2019) Noemi Antonella Guadagno et al.   Cells

CSF synaptic protein concentrations are raised in those with atypical Alzheimer’s disease but not frontotemporal dementia

(2019) Mica T. M. Clarke et al.   Alzheimers Research & Therapy

Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology

(2018) Erik Portelius et al.   ACTA NEUROPATHOLOGICA

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation

(2018) Charlotte E. Teunissen et al.   Alzheimers Research & Therapy

Quantitative proteomic profiling of cerebrospinal fluid to identify candidate biomarkers for Alzheimer's disease

(2018) Gajanan Sathe et al.   Proteomics Clinical Applications

Neuronal Pentraxin 2 predicts medial temporal atrophy and memory decline across the Alzheimer’s disease spectrum

(2016) Ashley Swanson et al.   BRAIN BEHAVIOR AND IMMUNITY

The clinical spectrum of sporadic and familial forms of frontotemporal dementia

(2016) Ione O. C. Woollacott et al.   JOURNAL OF NEUROCHEMISTRY

Presynaptic Neuronal Pentraxin Receptor Organizes Excitatory and Inhibitory Synapses

(2016) Sung-Jin Lee et al.   JOURNAL OF NEUROSCIENCE

Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer′s and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies

(2016) Patrick Oeckl et al.   MOLECULAR & CELLULAR PROTEOMICS

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

(2015) Hlin Kvartsberg et al.   Alzheimers & Dementia

Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF

(2015) Daniel S. Spellman et al.   Proteomics Clinical Applications

The Synaptic Function of α-Synuclein

(2015) Jacqueline Burré   Journal of Parkinsons Disease

Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease

(2014) Cassia R. Overk et al.   BIOCHEMICAL PHARMACOLOGY

Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging

(2012) David R. Roalf et al.   Alzheimers & Dementia

Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI

(2011) Leslie M. Shaw et al.   ACTA NEUROPATHOLOGICA

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

(2011) Thomas J. Montine et al.   ACTA NEUROPATHOLOGICA

Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update

(2009) Ian R. A. Mackenzie et al.   ACTA NEUROPATHOLOGICA